A systematic review published in the Cochrane Database of Systematic Reviews (2002) compared the effectiveness of early versus deferred androgen suppression therapy in men with advanced prostate cancer. The review, which analyzed data from 2,167 patients, found that early androgen suppression resulted in modest improvements in overall survival (18% vs.
